本頁面由Tiger Trade Technology Pte. Ltd.提供服務

X4製藥

3.50
+0.10002.94%
盤後3.500.00000.00%19:30 EDT
成交量:125.29萬
成交額:433.27萬
市值:3.47億
市盈率:-3.95
高:3.55
開:3.44
低:3.24
收:3.40
52周最高:4.83
52周最低:2.80
股本:9,914.67萬
流通股本:6,235.43萬
量比:0.91
換手率:2.01%
股息:- -
股息率:- -
每股收益(TTM):-0.8867
每股收益(LYR):-1.8726
淨資產收益率:-113.08%
總資產收益率:-28.15%
市淨率:2.23
市盈率(LYR):-1.87

資料載入中...

2026/09/09

重要事件披露

Form 8-K - Current report
2026/09/08

重要事件披露

Form 8-K - Current report
2026/08/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/01

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/05/13

SEC問詢函

Form CORRESP - Correspondence
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/03/18

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/17

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/11/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

重要事件披露

Form 8-K - Current report
2025/10/27

重要事件披露

Form 8-K - Current report